Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MEASURE

Financiado

Models of the maternal and fetal cardiovascular systems coupling via uterus and...

Models of the maternal and fetal cardiovascular systems coupling via uterus and placenta Complications occur in 5-10% of pregnancies, resulting every year in 2.6 million stillbirths and 303,000 maternal deaths. There is established evidence that complications and stillbirth are associated with abnormal development/ada... ver más

31/08/2025

TU/e

188K€

Presupuesto del proyecto: 188K€

Líder del proyecto

TECHNISCHE UNIVERSITEIT EINDHOVEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-08-22

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021 ExpectedOutcome:

I+D

Cerrada hace 3 años

0% 100% 100%

2 Participantes

TU/e

187.62K€ | Lider

PHILIPS ELECTRONICS NEDERLAN...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

InSilicoPlacenta Image-Based In Silico Modelling of Feto-Placental Vasculatur... 164K€ Cerrado

BES-2017-080587 MULTI-SCALE PHYSIOLOGY-DRIVEN COMPUTATIONAL TOOLS TO ASSIST... 93K€ Cerrado

TEC2008-02090 MODELO MULTI-ESCALA DEL CORAZON. APLICACION EN LA PREVENCION... 271K€ Cerrado

TIN2012-35874 INTEGRACION FISIOLOGICA DE INFORMACION MORFOLOGICA Y FUNCION... 34K€ Cerrado

TIN2012-37546-C03-02 CORAZON HUMANO COMPLETO FISIOLOGICO VIRTUAL: CAMBIOS ARQUITE... 25K€ Cerrado

DPI2015-71640-R HERRAMIENTAS COMPUTACIONALES PARA INVESTIGAR LA MORFOLOGIA Y... 236K€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2022-08-22
Fecha Fin: 2025-08-31

Líder del proyecto

TECHNISCHE UNIVERSITEIT EINDHOVEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 188K€

Descripción del proyecto Complications occur in 5-10% of pregnancies, resulting every year in 2.6 million stillbirths and 303,000 maternal deaths. There is established evidence that complications and stillbirth are associated with abnormal development/adaptation of the cardiovascular system (CVS) during pregnancy. However, the literature lacks a holistic approach and only a few limited aspects have been investigated. Therefore, MEASURE aims at pursuing a holistic investigation of the CVS and the coupling between its subsystems (fetal and maternal CVS), mediated by the uterus and placenta. Synchronized Doppler and electrophysiological acquisitions will be performed to produce a unique dataset for the identification of a mathematical model describing the CVS. This will be achieved through robust and accurate extraction of time series representing the characteristics of the CVS in healthy pregnancies. Through an innovative aggregating strategy proposed to improve clinical reliability, the obtained model will be translated into a coupling map, i.e., a graphical representation of the relationships between the CVS subsystems and their variables. Being more intuitive and easier to interpret, this representation is particularly suitable for its clinical use and uptake. Finally, the comparison between the coupling maps of healthy and complicated pregnancies will allow identifying anomalies in the interactions between the CVS subsystems and designing/training a machine learning classifier to automatically discern between them. The outcomes of MEASURE will improve our understanding of the physiological mechanisms underlying pregnancy and original causes of complications, paving the way for the development of novel, powerful, diagnostic tools for timely diagnosis and, possibly, prediction of pregnancy complications. The support of academic, industrial, and clinical partners will provide all the instruments to achieve the envisioned scientific breakthroughs and favour their clinical translation.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores